1672-P: Characterization of Immune Checkpoint Inhibitor–Mediated Hyperglycemia: Beyond Insulin-Dependent Diabetes

Immune checkpoint inhibitors (ICIs) treat cancer by augmenting patients’ (pts) immune responses against cancer. The immune activation from ICIs is associated with immune-related adverse events. Inflammation has a known association with hyperglycemia (HG) and insulin resistance. Little is known about...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2020-06, Vol.69 (Supplement_1)
Hauptverfasser:	LEITER, AMANDA, CARROLL, EMILY, BROOKS, DANIELLE C., SHIMOL, JENNIFER BEN, EISENBERG, ELLIOT, GALSKY, MATTHEW, GALLAGHER, EMILY
Format:	Artikel
Sprache:	eng
Schlagworte:	Autoimmune diseases Body mass index Cancer Diabetes Diabetes mellitus (insulin dependent) Glucose Hyperglycemia Immune checkpoint inhibitors Immune response Insulin Insulin resistance Obesity Risk factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!